B 12 -binding proteins decreased steadily throughout pregnancy. In the third trimester, 35% of the participants had serum vitamin B 12 concentrations <150 pmol/L and 68.6% had <15% saturation of total vitamin B 12 -binding capacities, but no women had RBC vitamin B 12 concentrations <148 pmol/L. However, the decrease in these indices was not associated with reduced hemoglobin concentrations or RBC count or with increased tHcy concentrations. Conclusions: Our findings suggest that the reference values for vitamin B 12 status in nonpregnant women may not be applicable to pregnant women.
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One of the biochemical functions of cobalamin (vitamin B 12 ) in mammals is to maintain normal folate metabolism, which is essential for cell multiplication during pregnancy. Because maternal vitamin B 12 stores in women eating a mixed diet are ϳ3000 g and the vitamin B 12 requirement of the fetus is ϳ50 g, it may be assumed that the event of a single pregnancy has minimal impact on maternal stores (1 ) . On the other hand, vitamin B 12 deficiency, defined as low serum vitamin B 12 concentrations, occurs in 10 -28% of uncomplicated pregnancies (2 ) .
At present little information is available regarding the normal changes in vitamin B 12 metabolism and concentrations of cobalamin-binding proteins during pregnancy (3 ) . Moreover, much of the reported information (4 -6 ) was collected before the availability of assays for measuring the biologically active form of vitamin B 12 . No reference values are available for most biochemical indices of vitamin B 12 status in pregnant women, and often the reference values for nonpregnant individuals are used to assess their vitamin B 12 status. To our knowledge, no longitudinal studies have been performed to validate the applicability of these reference values for pregnant women.
The aim of the present study was to obtain longitudinal information on the biochemical indices of vitamin B 12 status throughout pregnancy, especially erythrocyte and serum vitamin B 12 , holo-haptocorrin, unsaturated cobalamin-binding proteins, unsaturated vitamin B 12 -binding capacity (UBBC), 8 and total vitamin B 12 -binding capacity (TBBC) as well as other associated indices, such as total homocysteine (tHcy). In addition, the consequences of decreasing blood concentrations on associated hematologic indices were investigated. The values presented may be used as reference intervals for cobalamin-binding proteins and cobalamin-binding capacities for healthy pregnant women.
Subjects and Methods study design, participants, and dietary assessment
The study was designed as a prospective longitudinal study throughout pregnancy. Healthy pregnant volunteers (n ϭ 39) entered the study and were followed until delivery. Information on dietary intake and blood samples were collected in the first, second, and third trimesters of gestation (weeks 9 -12, 20 -22, and 36 -38). The study was approved by the Ethics Committee of the Division of Human Medicine, University of Giessen, Germany. All participants gave informed consent.
Descriptions of the design, the recruitment methods, and the conduction of the study have been published in detail elsewhere (7 ) . Briefly, the participants were apparently healthy adults. High-risk and twin pregnancies were excluded. A food frequency list was used to assess dietary habits. Interested women eating an average Western diet that corresponded with the average German population, as defined in the results of the German National Consumption Study, were selected by a priori defined selection criteria. Their diet consisted of Ͼ300 g of meat and 105 g of meat products per week. Because of missing laboratory data or relocation and birth of the child before the last blood sampling date, the calculation of ratios of vitamin B 12 concentrations in the third to the first trimester is based on a subgroup of 29 pregnant women.
Linked to the blood sampling, a 4-day food record, including categories of 152 food items with given portion sizes estimated by typical household measures, was maintained three times throughout the pregnancy by all participants (8 ) . The calculation of food-derived cobalamin intake was based on the German Food Code and Nutrition Data Base BLS II. 3 (9 ) . Folate and cobalamin concentrations in multivitamin-fortified juices were taken from producers' data. In addition, the intake of food supplements and medication during the record period were registered.
analytical methods
Venous blood was drawn after an overnight fast and immediately stored at 4 -7°C. The analyses of hemoglobin (Hb), and red blood cell (RBC) indices [mean corpuscular volume (MCV) and RBC count] were performed on a Coulter Counter STKS (Beckman Coulter). Between-run CVs (n ϭ 10) were 0.8% for Hb, 0.6% for MCV, and 1.1% for RBC count. Plasma and serum were separated from blood cells within 2 h of venipuncture and stored frozen (Ϫ18°C) until assayed. Serum ferritin concentrations were analyzed by the Enzymun ® assay for ferritin (Roche Diagnostics GmbH); the between-run CV was 5.4% (n ϭ 8; mean concentration, 30 g/L).
For analysis of RBC vitamin B 12 , a 20% erythrocyte solution was prepared immediately according to the method of Tisman et al. (10 ) and was stored frozen until analysis within 6 -12 months. Vitamin B 12 concentrations in the red cell extracts were determined using the Ciba Corning Magic no-boil radioassay (Ciba Corning Diagnostics Corp.); the between-run CV (n ϭ 10; mean concentration, 362 pmol/L) was 10%. Serum vitamin B 12 concentrations were analyzed by the IMx cobalamin assay (Abbot Diagnostics Division), which incorporates microparticles coated with porcine intrinsic factor to bind cobalamin.
Holo-haptocorrin was analyzed by a modification of the method recommended by Das et al. (11 ) as described by Wickramasinghe and Fida (12 ) . Briefly, a slurry containing synthetic amorphous precipitated silica (Sipernet 283 LS; PQ Corporation) in distilled water was prepared and stored at 4°C. Holo-transcobalamin was absorbed by adding silica to the serum, vortex-mixing the mixture, and letting it stand for 10 min. The mixture was centrifuged, and the supernatant fluid was assayed for vitamin B 12 using the IMx cobalamin assay. The value obtained represents the holo-haptocorrin concentration. The betweenrun CVs were was 5.1% (n ϭ 10; mean concentration, 303 pmol/L for serum vitamin B 12 ) and 5.4% (n ϭ 15; mean concentration, 138 pmol/L) for holo-haptocorrin. UBBC and unsaturated cobalamin-binding proteins were determined according to the methods of Gottlieb et al. (13 ) and Jacob and Herbert (14 ) . Radioactive vitamin B 12 labeled with 57 Co was added to the samples. After adsorption of free vitamin B 12 to charcoal, total UBBC was measured with the Gamma Master 1277 (LKB Wallac). Microfine silica (Quso G35) was used to separate apo-transcobalamin from apo-haptocorrin. The unsaturated haptocorrin binding capacity was analyzed, and the unsaturated transcobalamin binding capacity was calculated by subtracting the unsaturated haptocorrin binding capacity from UBBC. The between-run CVs (n ϭ 20) were 6.5% for UBBC (mean concentration, 1100 pmol/L), 3% for apohaptocorrin (mean concentration, 154 pmol/L), and 7.4% for apo-transcobalamin (mean concentration, 952 mol/L).
RBC and plasma folate concentrations were determined with a chemiluminescent competitive proteinbinding assay (ACS Folate Assay; Ciba Corning Diagnostics GmbH). The between-run CV was 3.9% (n ϭ 15; mean concentration, 412 nmol/L) for RBC folate and 4.1% (n ϭ 13; mean concentration, 16.4 nmol/L) for plasma folate. The tHcy concentration was measured in plasma according to the methods of Ubbink et al. (15 ) and Araki and Sako (16 ) . For quantification, the samples were analyzed without and with the addition of a standard amount of tHcy; the average response factors for the added tHcy were used to calculate the concentration of endogenous tHcy. Recoveries in individual samples deviating Ͼ10% from the mean were rejected, and the measurement was repeated. The between-run CV (n ϭ 20) for tHcy was 4% at a mean concentration of 8.3 mol/L. Blood smears were prepared on glass slides and stained by the Pappenheim method (17, 18 ) . Segmentation of neutrophil granulocytes was counted twice from two different blood smears of each woman. The blood smears were subjected to a lobe count (100 nuclei) according to the method of Bung et al. (19 ) . Intraindividual counts that deviated Ͼ20% were counted two additional times; the mean value of all four counts was used for data analysis. The CV (n ϭ 9; mean, 2.9 lobes) was 14%. Low haptocorrin saturation and TBBC were defined as Ͻ20% and Ͻ15%, respectively, based on Herbert (21 ) . Folate deficiency was defined as RBC folate concentrations Ͻ320 nmol/L (22 ) .
Plasma folate, serum vitamin B 12 , apo-haptocorrin, and neutrophil segmentation index were log-transformed to normalize the data. To test the effect of stage of pregnancy (first, second, and third trimester) on biochemical indices during pregnancy, generalized estimating equations were used. Generalized estimating equation models allow appropriate analysis of longitudinal data with repeated measurement and missing values. The effect of potentially confounding variables (i.e., maternal age, BMI, parity, and use of oral contraceptives) was tested. All two-way interactions were tested, but no interactions with P Ͻ0.15 were found. On the basis of the results of these preliminary analyses, final models included maternal age as the only confounding variable. All analyses were performed using SAS 8.2 (SAS Institute Inc.).
Results

dietary intake and other characteristics of the study population
The mean age of the participating pregnant volunteers was 29.1 Ϯ 3.6 years, and the mean BMI before pregnancy was 23.1 Ϯ 4.7 kg/m 2 . The mean parity was 2.0 Ϯ 1.1, and 41% of the participants were primiparous. Four women had more than two previous deliveries, and 12 women took oral vitamin B 12 supplements. None of the pregnant women had a twin pregnancy. Eighteen women had taken oral contraceptives within the past 12 months preceding pregnancy. The analysis of covariance showed no effect of BMI, parity, use of oral contraceptives, or cobalamin intake on biochemical indices of vitamin B 12 status. The exclusion of women who had more than two previous deliveries and who took oral vitamin B 12 supplements did not significantly change any of the reported results.
The mean intake of dietary vitamin B 12 from first to third trimester was 5.6 Ϯ 2.0 g/day. None of the participants had an average vitamin B 12 intake below the Recommended Dietary Allowance (RDA) of 2.6 g/day at any time during pregnancy (22 ) . The intake of vitamin B 12 did not correlate with vitamin B 12 concentrations in blood. The mean intake of dietary folate from first to third trimester was 273 Ϯ 53 g/day. Seventeen women (44%) took folate supplements during the current pregnancy. Folate deficiency was observed in 14 women (36%).
rbc and serum vitamin b 12 concentrations
RBC and serum vitamin B 12 concentrations are shown in Table 1 . The ratios of selected concentrations of the third relative to the first trimester are shown in Table 2 . Serum vitamin B 12 concentrations decreased steadily throughout pregnancy. Only one woman showed low serum vitamin B 12 concentrations (Ͻ150 pmol/L) in the first trimester of pregnancy.
Throughout pregnancy, 3 women (8%) in the second and 12 women (35%) in third trimester developed low serum vitamin B 12 concentrations. In contrast, RBC vitamin B 12 concentrations increased significantly during this period. Low RBC vitamin B 12 concentrations (Ͻ148 pmol/L) were observed in four women in the first trimester and in one woman in the second trimester; RBC vitamin B 12 concentrations Ͻ133 pmol/L were observed in two woman in the first trimester and in one women in the second trimester. No woman with low serum vitamin B 12 concentrations simultaneously showed low RBC vitamin B 12 concentrations (Ͻ148 pmol/L). Similar to the serum vitamin B 12 concentrations, a steady decrease in holo-haptocorrin concentrations was observed.
Serum vitamin B 12 concentrations and holo-haptocorrin decreased with increasing maternal age (P ϭ 0.041 and 0.035, respectively). No differences between primiparous and nonprimiparous women were observed. No interactions between maternal age and the decreases in serum vitamin B 12 and holo-haptocorrin concentrations between first and third trimester were observed, implying that the degree of decrease was not modified by maternal age.
concentrations of cobalamin-binding proteins and vitamin b 12 -binding capacities
The UBBC and TBBC of the serum increased steadily during pregnancy. TBBC, which also depends on decreasing serum vitamin B 12 concentrations, increased less. In the third trimester, 68.6% of women had a TBBC saturation Ͻ15%. Whereas the apo-transcobalamin changed only marginally during pregnancy, apo-haptocorrin increased sharply. Consequently, the ratio of apo-transcobalamin and apo-haptocorrin also changed significantly.
consequences of low vitamin b 12 concentrations
Most of the indicators of vitamin B 12 status in the present study, including Hb, MCV, RBC count, neutrophil segmentation, and plasma and RBC folate concentrations, as well as tHcy concentrations changed significantly during pregnancy. However, results of an analysis of variance showed that changes in any of the above indicators were not affected by vitamin B 12 status, but by folate deficiency (data not shown). After adjustment for RBC folate as a predictor for folate status, no differences were observed for tHcy concentrations and neutrophil segmentation between women with low vs normal serum vitamin B 12 concentrations in the second and third trimesters. After adjustment for serum ferritin concentrations as a predictor for iron status, no differences were observed for Hb, MCV, and RBC count between women with low vs normal serum vitamin B 12 concentrations in the second and third trimesters. In addition, no difference was observed in plasma and RBC folate. Different cutoff values for serum vitamin B 12 were used to define low serum vitamin B 12 concentrations: Ͻ150, Ͻ200, and 250 pmol/L.
In the second and third trimesters, women with low (Ͻ15%) and normal TBBC saturation did not differ with respect to any of the above indicators of vitamin B 12 status.
Discussion
Although recent studies have shown that vitamin B 12 deficiency can occur during pregnancy, only limited information is available regarding normal changes in the vitamin B 12 -binding capacities and saturation of the cobalamin-binding proteins during pregnancy (4, 5 ) . More- The present study provides longitudinal values for most biochemical indices of vitamin B 12 status, which may be interpreted as preliminary reference values for healthy women during pregnancy. Because more than one-third of the participants (36%) showed signs of folate deficiency, the presented blood indices affected by both vitamin B 12 and folate are not suitable as indicators of vitamin B 12 deficiency.
Unsaturated concentrations of cobalamin-binding proteins showed a steady increase over the course of the pregnancies. It may be noted that this finding differs from the results of Fernandes-Costa and Metz (4 ), who observed a moderate decrease in apo-transcobalamin concentrations between the first and second trimesters, followed by a strong increase near delivery. However, the apo-transcobalamin concentrations reported by these authors may be of limited value because they used chicken serum as a competitive binder for the cobalamin assay.
Unsaturated apo-haptocorrin concentrations increased markedly after the second trimester, confirming the results of other studies (4, 5 ) . At present, the role of increased apo-haptocorrin during pregnancy in human serum is not known. In rabbits, only small amounts of injected holo-haptocorrin were transferred to the placenta, and haptocorrin seems to play a minor role for the supply of the fetus (25 ) . Because evidence in the literature suggests a role of haptocorrin in scavenging nonphysiologic vitamin B 12 analogs, it was suggested that haptocorrin may be important to protect the fetus from these potentially harmful compounds (26, 27 ) .
In conclusion, the present study indicates that reference values established for nonpregnant women are not suitable for assessing vitamin B 12 status in pregnant women. Furthermore, our results suggest that the observed changes in concentrations of cobalamin-binding proteins reflect physiologic changes during pregnancy rather than vitamin B 12 deficiency. Further studies are needed to confirm the observed changes in cobalamin-binding proteins during pregnancy and their physiologic implications.
